Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s patented precision optical filter lens has demonstrated both clinical and statistical superiority over placebo in a randomized double-masked clinical trial for managing light sensitivity and pain in migraine patients. Real-world data show that up to 90% of users can resume daily activities while using the lenses to manage symptoms. The product has regulatory clearance as a Class I Medical Device in Canada and has been adopted by hundreds of eye care providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avulux.